Enzymes
Product List
KLK10 Human, Sf9
Kallikrein-10 Human Recombinant, Sf9
KLK10 produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 252 amino acids (34-276 a.a) and having a molecular mass of 27.8kDa.
KLK10 protein is fused to a 6 amino acid His-Tag at C-terminus and purified by standard chromatography.
Sf9, Baculovirus cells.
KLK1 Human, HEK
Kallikrein-1 Human Recombinant, HEK
KLK1 Human Recombinant produced in HEK293 cells is a single, glycosylated, polypeptide chain containing 244 amino acids ( Pro19-Ser262 ).
KLK-1 is expressed with an 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
KLK1 Human, His
Kallikrein-1 Human Recombinant, His Tag
Kallikrein-1 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 259 amino acids (25-262) and having a molecular mass of 28.7kDa.
KLK1 is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
KLK10 Human
Kallikrein-10 Human Recombinant
KLK10 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
KLK11 Human
Kallikrein-11 Human Recombinant
KLK11 Human, Sf9
Kallikrein-11, 4 Human Recombinant, Sf9
KLK11 produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 241 amino acids (19-250a.a.) and having a molecular mass of 26.7 kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).
KLK11 is expressed with a 9 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.
Sf9, Insect cells.
KLK13 Human
Kallikrein-13 Human Recombinant
KLK13 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
KLK13 Human, sf9
Kallikrein-13 Human Recombinant, sf9
KLK15 Human
Kallikrein-15 Human Recombinant
KLK15 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.
KLK15 Human, sf9
Kallikrein-15 Human Recombinant, sf9
KLK15 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 249 amino acids (17-256a.a.) and having a molecular mass of 27.4kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa).
KLK15 is expressed with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques.
Introduction
Kallikreins are a subgroup of serine proteases, enzymes capable of cleaving peptide bonds in proteins. In humans, they are classified into two main types: plasma kallikrein and tissue kallikreins. Plasma kallikrein is encoded by the KLKB1 gene and has no known paralogue, while tissue kallikrein-related peptidases (KLKs) encode a family of fifteen closely related serine proteases . These genes are localized to chromosome 19q13, forming the largest contiguous cluster of proteases within the human genome .
Key Biological Properties: Kallikreins are involved in various physiological functions, including blood pressure regulation, semen liquefaction, and skin desquamation .
Expression Patterns and Tissue Distribution: Kallikreins are expressed in many tissues, including the prostate, breast, ovary, and testis . They are also found in biological fluids such as seminal plasma, breast milk, and cerebrospinal fluid . Some kallikreins have restricted expression patterns, while others are widely distributed across different tissues .
Primary Biological Functions: Kallikreins play a crucial role in regulating blood pressure, semen liquefaction, and skin desquamation . They are also involved in the activation of inflammation and the regulation of electrolyte balance .
Role in Immune Responses and Pathogen Recognition: Kallikreins are implicated in immune responses by activating kinins, which are peptides responsible for inflammation and vasodilation . They also play a role in pathogen recognition by modulating the activity of immune cells .
Mechanisms with Other Molecules and Cells: Kallikreins interact with various molecules and cells through proteolytic cascades. For example, plasma kallikrein liberates kinins from kininogens, which regulate blood pressure and inflammation .
Binding Partners and Downstream Signaling Cascades: Kallikreins bind to kininogens to release kinins, which then activate B1 and B2 receptors, leading to downstream signaling cascades that regulate blood pressure, inflammation, and other physiological processes .
Regulatory Mechanisms Controlling Expression and Activity: Kallikrein expression is regulated by steroid hormones such as androgens, estrogens, and glucocorticoids . Their activity is controlled through zymogen activation, endogenous inhibitors like serpins, and internal (auto)cleavage leading to inactivation .
Transcriptional Regulation and Post-Translational Modifications: Kallikreins undergo transcriptional regulation by steroid hormones and post-translational modifications such as glycosylation, which affect their stability and activity .
Biomedical Research: Kallikreins are studied for their role in various physiological and pathological processes, including cancer, cardiovascular diseases, and neurodegenerative disorders .
Diagnostic Tools: Prostate-specific antigen (PSA; KLK3) and human glandular kallikrein (hK2) are used as tumor markers for prostate cancer . Other kallikreins are emerging as biomarkers for ovarian and breast cancers .
Therapeutic Strategies: Kallikrein inhibitors are being developed for the treatment of hereditary angioedema and other inflammatory conditions . Recombinant tissue kallikrein is also being explored for therapeutic use in ischemic stroke and renal disease .
Role Throughout the Life Cycle: Kallikreins play a role in various stages of life, from development to aging and disease. They are involved in skin desquamation, seminal clot liquefaction, and neurodegenerative disorders such as Parkinson’s and Alzheimer’s diseases . Dysregulated kallikrein expression is associated with cancer progression and other age-related diseases .
